Skip to Content
Merck
CN

EMU158121

MISSION® esiRNA

targeting mouse Dtx3l

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

NACRES:
NA.51
UNSPSC Code:
41105324
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


description

Powered by Eupheria Biotech

Quality Level

product line

MISSION®

form

lyophilized powder

esiRNA cDNA target sequence

CTAACTCTGTTGACTCAGTTGTCCAAAAGATCTTTCTTGCTGTGACCGCTGAGCTGAACTGTGACCTGCTCTCTAAAGAGCAGAGAGCATCTATAACCACTGTCTGCCCTCACATCATCAAAAGCATGGAGGGTAGTGATGGAATTAAGAAGGTGTGTGGCAACTTCAAAGATATTGAAAAGATACATCACTTCTTGAGTGAGCAGCTTTTGGAACGGGAGCAGAAACGGAAGGGAAGCGAGCAGAAACGGAAGTGCGCCCCACAGAAACACACACCTCCCGATGTGGAGCGGGAGCCCCCTGATCAGAGCAGTATTCAAGTTCCTGTGCTTCTCCTTGAATATTTCAAGCATGTTAATCCGGGTAGACTAGAGTTCATAGAGTACAAATTTGGTGTAAACATTGAAATCCAAGCTAGTTCTCCCAATATGGTCACTGTAGGCTTCACCTCCAGCCCATTTGGCAACGTAGAAGAAGCAAGTCAGTCCTTTGTCAGAGACTTTCAGAAAT

Ensembl | mouse accession no.

NCBI accession no.

shipped in

ambient

storage temp.

−20°C

Gene Information

General description

MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.

For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.

Legal Information

MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany


Storage Class

10 - Combustible liquids

flash_point_f

Not applicable

flash_point_c

Not applicable

Regulatory Information

新产品

This item has



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



Danielle P Johnson et al.
Oncotarget, 6(7), 4863-4887 (2015-01-22)
Gain-of-function mutations in the catalytic site of EZH2 (Enhancer of Zeste Homologue 2), is observed in about 22% of diffuse large B-cell lymphoma (DLBCL) cases. Here we show that selective inhibition of histone deacetylase 1,2 (HDAC1,2) activity using a small



Global Trade Item Number

SKUGTIN
EMU158121-20UG04061828770991
EMU158121-50UG04061828735655